anticancer/atrophy

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of

FIELD OF THE INVENTION The present invention relates to therapeutic compounds for treatment of cancer and disorders associated with angiogenesis function. More specifically, the invention relates to novel compounds and their uses in treating cancer such as leukemia, non-small cell lung cancer, colon

BACKGROUND Locally advanced or locally invasive solid tumors are primary cancers that have extensively invaded or infiltrated into the otherwise healthy tissues surrounding the site where the tumor originated. Locally advanced tumors may arise in tissues throughout the body, but unlike early stage

TECHNICAL FIELD The present application relates to the medicine field, specifically to a new chlorin photosensitizer, chlorin e6 ether amino acid derivatives and pharmaceutically acceptable salt thereof, process for preparing and use in preparing anti-tumor drugs, etc. BACKGROUND OF THE

The following non-limiting examples illustrate several examples for the preparation of the active compounds of Formula I according to the present invention, as well as examples of compositions containing these active compounds. EXAMPLE 1 Methyl ester of 6-(3-methylphenyl)-2-naphthoic acid. Compound

The present invention relates to benzonaphthalene derivatives, to a process for preparing them and to their use in therapeutic and cosmetic compositions. These new benzonaphthalene derivatives are usefully employed in the topical and systemic treatment of dermatological diseases linked to

The present invention relates to benzonaphthalene derivatives, to a process for preparing them and to their use in therapeutic and cosmetic compositions. These new benzonaphthalene derivatives are usefully employed in the topical and systemic treatment of dermatological diseases linked to

The present invention relates to benzonaphthalene derivatives, to a process for preparing them and to their use in therapeutic and cosmetic compositions. These new benzonaphthalene derivatives are usefully employed in the topical and systemic treatment of dermatological diseases linked to

The present invention relates to benzonaphthalene derivatives, to a process for preparing them and to their use in therapeutic and cosmetic compositions. These new benzonaphthalene derivatives are usefully employed in the topical and systemic treatment of dermatological diseases linked to

BACKGROUND OF THE INVENTION The present invention relates to phosphinate based derivatives which are inhibitors of matrix metalloproteinases or the production of tumor necrosis factor (TNF) and as such are useful in the treatment of a condition selected from the group consisting of arthritis,

TECHNICAL FIELD The present invention relates to a pyridine derivative having an ability to act as a neurotrophic factor and a salt thereof. BACKGROUND ART It has been suggested that in Alzheimer's disease, which has recently been increasing in prevalence, degeneration and dysfunction of cholinergic

TECHNICAL FIELD This invention relates to enzyme inhibitors, and more particularly to histone deacetylase inhibitors. BACKGROUND DNA in the nucleus of the cell exists as a hierarchy of compacted chromatin structures. The basic repeating unit in chromatin is the nucleosome. The nucleosome consists of

TECHNICAL FIELD This invention relates to trihalomethylcarbonyl compounds, and more particularly to trihalomethylcarbonyl compounds that are histone deacetylase inhibitors. BACKGROUND DNA in the nucleus of the cell exists as a hierarchy of compacted chromatin structures. The basic repeating unit in

TECHNICAL FIELD This invention relates to alpha-ketoepoxide compounds, and more particularly to alpha-ketoepoxide compounds that are histone deacetylase inhibitors. BACKGROUND DNA in the nucleus of the cell exists as a hierarchy of compacted chromatin structures. The basic repeating unit in

TECHNICAL FIELD This invention relates to alpha-ketoepoxide compounds, and more particularly to alpha-ketoepoxide compounds that are histone deacetylase inhibitors. BACKGROUND DNA in the nucleus of the cell exists as a hierarchy of compacted chromatin structures. The basic repeating unit in